Search results
'Seems Low:' Elon Musk Questions Pfizer's $0 Tax Bill, But Did Tesla Pony Up To Uncle Sam? - Pfizer...
Benzinga· 4 days agoClair, a contributor to satirical outlet The Babylon Bee, shared a blog post. The post alleged the...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher? | The Motley Fool
The Motley Fool· 2 days agoThe market was responding to terrific news from Sanofi (NASDAQ: SNY), a global pharmaceutical giant...
The Zacks Analyst Blog Highlights Amazon, Visa, Pfizer, Martin Marietta Materials and Zimmer Biomet
Zacks via Yahoo Finance· 3 days agoThe company beat first-quarter estimates for earnings but missed the same for sales. Pfizer’s top...
3 No-Brainer Stocks to Buy With $500 Right Now
Motley Fool via Yahoo Finance· 1 day agoOver the last two years, one of Wall Street's largest drug developers became a victim of its own success. During the COVID-19 pandemic, Pfizer was one of...
Being vaccinated against COVID-19 reduces the severity of the illness
Digital Journal· 7 days agoA new study reveals how COVID-19 vaccines prevent severe disease. This is based on research...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks via Yahoo Finance· 3 days agoThe CDC has also recommended the use of both GSK and Pfizer’s RSV vaccines for older adults. GSK’s...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 6 days agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Aaron Rodgers slammed over Vladimir Putin, Joe Biden remark
Newsweek· 1 day agoAaron Rodgers has been slammed for his recent comments on President Joe Biden and Russian President...
The 3 Most Undervalued Healthcare Stocks to Buy in May 2024
InvestorPlace· 6 days agoA commonly used strategy for investing is sector rotation. A good example is the flow of funds into...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 6 days agoWhy it matters: It's a major turnaround for Maryland-based Novavax, one of America's first big bets...
